A case of acquired immunodeficiency syndrome-related Kaposi sarcoma in a patient with COVID-19 - A brief review of HIV-COVID Co-infection and its Therapeutic challenges!
- PMID: 34631405
- PMCID: PMC8492423
- DOI: 10.1016/j.rmcr.2021.101524
A case of acquired immunodeficiency syndrome-related Kaposi sarcoma in a patient with COVID-19 - A brief review of HIV-COVID Co-infection and its Therapeutic challenges!
Abstract
Barriers posed by the COVID-19 pandemic have led to reduced access to Human Immunodeficiency virus (HIV) care, leaving untreated patients at risk for various superimposed infections and malignancies such as Kaposi sarcoma (KS). We recently encountered a 37-year-old African-American male with a past medical history of HIV who tested positive for SARS-CoV-2 and was diagnosed with AIDS-related disseminated KS, representing the first reported case of COVID-19 infection with a newly diagnosed concomitant KS. The patient experienced multi-organ failure requiring tracheostomy, renal replacement therapy, and a prolonged intensive care unit (ICU) stay. Goals of care were changed to comfort measures and the patient passed away shortly afterwards. He was made comfort measures and passed away shortly afterwards. AIDS-related KS is a vascular tumor seen in association with Human Herpes Virus-8 (HHV-8). Management of limited AIDS-related KS typically includes combined antiretroviral therapy (ART) while multi-organ KS disease demands systemic chemotherapy. Immunosuppression should be avoided in patients with AIDS-related KS as it can lead to progression of KS. This recommendation is in conflict with the usual standard of care for patients with COVID-19 pneumonia, requiring clinical judgment and a customized approach based on the stage and severity of both the KS and the COVID-related disease. We briefly review HIV-COVID-19 coinfection, AIDS related KS and challenges associated with their management.
Keywords: COVID-19; HHV-8; HIV; Kaposi sarcoma; Social inequities.
© 2021 Published by Elsevier Ltd.
Conflict of interest statement
The other authors report no conflicts of interest.
Figures





Similar articles
-
Spurious Presentation of Pulmonary Kaposi Sarcoma as Unresolved Pneumonia Led to Fatal Outcome.J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231208996. doi: 10.1177/23247096231208996. J Investig Med High Impact Case Rep. 2023. PMID: 37919962 Free PMC article.
-
Kaposi sarcoma can also involve the heart.J Community Hosp Intern Med Perspect. 2015 Dec 11;5(6):29054. doi: 10.3402/jchimp.v5.29054. eCollection 2015. J Community Hosp Intern Med Perspect. 2015. PMID: 26653688 Free PMC article.
-
Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.Clin Infect Dis. 2010 Aug 1;51(3):342-9. doi: 10.1086/654800. Clin Infect Dis. 2010. PMID: 20572760
-
Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature.Eur J Med Res. 2021 Dec 20;26(1):152. doi: 10.1186/s40001-021-00620-9. Eur J Med Res. 2021. PMID: 34930492 Free PMC article. Review.
-
Kaposi's sarcoma: a reevaluation.Recent Results Cancer Res. 1995;139:275-96. Recent Results Cancer Res. 1995. PMID: 7541146 Review.
Cited by
-
Unusual Localization of AIDS-Related Kaposi's Sarcoma in a Heterosexual Male during the COVID-19 Pandemic: A Case Report.Trop Med Infect Dis. 2024 Feb 13;9(2):47. doi: 10.3390/tropicalmed9020047. Trop Med Infect Dis. 2024. PMID: 38393136 Free PMC article.
-
Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients.Viruses. 2024 Mar 13;16(3):448. doi: 10.3390/v16030448. Viruses. 2024. PMID: 38543814 Free PMC article.
-
SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia.J Immunol Res. 2022 Jul 28;2022:2114285. doi: 10.1155/2022/2114285. eCollection 2022. J Immunol Res. 2022. PMID: 35935575 Free PMC article.
References
-
- Vizcarra P., Pérez-Elías M.J., Quereda C., Moreno A., Vivancos M.J., Dronda F., Casado J.L., Moreno S., Pérez-Elías M.J., Fortún J., Navas E., Quereda C., Dronda F., Del Campo S., López-Vélez R., Cobo Reinoso J., Casado J.L., Moreno A., Norman F., Martín-Dávila P., Hermida J.M., Pérez Molina J.A., Monge B., Pintado V., Serrano-Villar S., Sánchez-Conde M., Chamorro S., Escudero R., Gioia F., Comeche B., Crespillo C., Herrera S., Ron R., Martínez-Sanz J., Pons-Guillén M., Vivancos M.J., Vizcarra P. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. The Lancet HIV. 2020;7(8):e554–e564. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous